Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vania Manolova

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Hemasphere|September 13, 2024
The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosisNaja Nyffenegger, Anna Flace, Ahmet Varol, et al.
Clinical Immunology (Orlando, Fla.)|March 16, 2026
Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot studyDivya Katikaneni, Tanmay Arekar, Leena Al-Hraki, et al.
European Journal of Immunology|April 7, 2006
Functional CD1a is stabilized by exogenous lipidsVania Manolova, Magdalena Kistowska, Samantha Paoletti, et al.
International Journal of Molecular Sciences|March 10, 2022
Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron-Carbohydrate Nanoparticles from SerumTasneem Arsiwala, Anne-Cathrine S Vogt, Amy E Barton, et al.
Blood|October 22, 2024
Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical studyAda Antypiuk, S Zebulon Vance, Richa Sharma, et al.
Frontiers in Immunology|March 22, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based VaccinesAriane C Gomes, Anna Flace, Philippe Saudan, et al.
Elife|March 21, 2023
Structures of ferroportin in complex with its specific inhibitor vamifeportElena Farah Lehmann, Márton Liziczai, Katarzyna Drożdżyk, et al.
Journal of Virology|October 28, 2004
CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivoErika Schlaepfer, Annette Audigé, Barbara von Beust, et al.
Expert Review of Hematology|July 29, 2021
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical developmentJohn Porter, Ali Taher, Vip Viprakasit, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2010
Mechanisms of allergen-specific desensitizationChristina Uermösi, Roger R Beerli, Monika Bauer, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Hemasphere|September 13, 2024
The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosisNaja Nyffenegger, Anna Flace, Ahmet Varol, et al.
Clinical Immunology (Orlando, Fla.)|March 16, 2026
Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot studyDivya Katikaneni, Tanmay Arekar, Leena Al-Hraki, et al.
European Journal of Immunology|April 7, 2006
Functional CD1a is stabilized by exogenous lipidsVania Manolova, Magdalena Kistowska, Samantha Paoletti, et al.
International Journal of Molecular Sciences|March 10, 2022
Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron-Carbohydrate Nanoparticles from SerumTasneem Arsiwala, Anne-Cathrine S Vogt, Amy E Barton, et al.
Blood|October 22, 2024
Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical studyAda Antypiuk, S Zebulon Vance, Richa Sharma, et al.
Frontiers in Immunology|March 22, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based VaccinesAriane C Gomes, Anna Flace, Philippe Saudan, et al.
Elife|March 21, 2023
Structures of ferroportin in complex with its specific inhibitor vamifeportElena Farah Lehmann, Márton Liziczai, Katarzyna Drożdżyk, et al.
Journal of Virology|October 28, 2004
CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivoErika Schlaepfer, Annette Audigé, Barbara von Beust, et al.
Expert Review of Hematology|July 29, 2021
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical developmentJohn Porter, Ali Taher, Vip Viprakasit, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2010
Mechanisms of allergen-specific desensitizationChristina Uermösi, Roger R Beerli, Monika Bauer, et al.
Pageof 4